Day Traders, Penny Stocks, Stock Options, Futures and Forex

YUCAIPA, Calif., Jan. 15, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading manufacturer of respiratory medical devices, recently announced that they will engage Medical Strategies International (MSI) to increase sales of the Oxyview product line through GPO contracts. The company points to the increasing prevalence of respiratory diseases, emerging hospital markets, and developing world markets. The CEO will discuss this with host Steve Crowley today at 9:34AM eastern standard time on the world renowned Money Channel's American Scene Radio.



The company projects that the Oxyview Nasal Cannula will bring $10M in revenues, and the new Oxyview Pulse Oximeter an additional $1M in revenues in 2010.



The Money Channel // American Scene Radio // WallStreetCast

IGNT-

+5%
RSI 42.72
@ .0020 next resistance .0022
MACD is starting 2 step over bullish

news out this morning
I anticipate an above average day

IGNT-

+5%
RSI 42.72
@ .0020 next resistance .0022
MACD is starting 2 step over bullish

news out this morning

IGNT a leading manufacturer of respiratory medical devices, recently announced that it has received several bulk purchases from various hospitals around the country. Columbia Memorial Hospital submitted a bulk purchase order for the new Oxyview Pulse Oximeter, and this is a strong indication of increased sales for 2010.Watch for a solid run today!!

Ingen Opens Doors With Hospital Purchases
The Company Signs a Contract for MediGroup GPO Proposal

YUCAIPA, Calif., Jan 21, 2010 (GlobeNewswire via COMTEX) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading manufacturer of respiratory medical devices, recently announced that it has received several bulk purchases from various hospitals around the country. Columbia Memorial Hospital submitted a bulk purchase order for the new Oxyview Pulse Oximeter, and this is a strong indication of increased sales for 2010.
On January 14, 2010, the company received a purchase order from the Oregon based Columbia Memorial Hospital for the new Oxyview Pulse Oximeter. The Company has signed a contract with MediGroup to develop various GPO proposals and will move forward this quarter to align strategic national GPO contracts with the hospital industry.
"We look forward to working with Andy Klearman, President of MediGroup. This group was brought to the table by Charles Vorwaller, one of our Board of Directors. We expect to sell all of our products to hospitals, and MediGroup has the expertise to develop this distribution channel for the company," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.

Photo Release -- Ingen Targets Lung Specialists With Oxyview Products
COPD Foundation Will Include Oxyview Ad in Their New Publication for Next Month

.Companies:Ingen Technologies, Inc..Press Release Source: Ingen Technologies, Inc. On Wednesday January 27, 2010, 8:15 am

YUCAIPA, Calif., Jan. 27, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading manufacturer of respiratory medical devices, recently announced today that it has approved an insertion order with COPD Foundation's new magazine that targets 20,000-30,000 lung specialists that includes physicians, respiratory therapists, nurse practitioners, and other lung specialists.










A photo accompanying this release is available at GlobeNewswire, Inc.


The company already has a 12 month contract with the COPD Foundation's COPD Digest magazine that is distributed once each quarter to over 200,000 subscribers. The new magazine will be released next month and includes articles and submissions by a variety of academics and clinicians, and will be focused on articles of interest to those treating patients with pulmonary diseases. These lung specialists represent 15,000,000 patients with COPD and various lung disorders in the USA.



"We look forward to working with Mitch Ruttner of the COPD Foundation and supporting the efficacy of their program. Mr. Ruttner has also been very proactive with our Oxyview product line, as we continue to direct a strong focus in the commercial hospital markets to sell our products. We continue to see an increase with hospital orders for bulk purchases, and this is an indicator that our Oxyview products are being recognized by hospitals. We are very appreciative for all of the support Ingen continues to receive from credible sources and shareholders," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.



COPD Digest | Programs | COPD Foundation


MedOx Corporation - Welcome


Oxyview Nasal Cannula - About Us - Yucaipa, CA


Ingen Technologies,Inc. - Home

Ignt had news today.Stock is trading well today. Myself and other smart money have taken a position in this stock today. We should see more price aprecation today and this week. The new magazine insert should bring more focus towards the company and the great products they produce. This company has a bright future and we can all profit from it. Remember this is my opinion and to do your own dd. Hope all your stocks are in the green!!!

Ingen Takes Final Steps Towards Increased Export Sales
ISO Auditor Approves Stage-I for Ingen

.Companies:Ingen Technologies, Inc..Press Release Source: Ingen Technologies, Inc. On Tuesday February 9, 2010, 8:15 am

YUCAIPA, Calif., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading manufacturer of respiratory medical devices, recently announced today that the company was granted approval of the Stage-I audit conducted by BSI America, Inc. on February 5, 2010.



On February 5, 2010 the company was audited by Mr. Brian Nguyen, one of the certified auditors with BSI America, Inc. According to Mr. Nguyen, Ingen's management system documentation meets the requirements of the ISO 13485:2003, the MDD 93/42/EEC Annex V (M5), and the CMDR. The internal audits and management review processes are being planned and performed. Based on the objective evidences noted from the areas assessed during this Stage-I audit, it is recommended that Ingen proceed to the final Stage-II audit. There were no outstanding non-conformities to review from previous assessments. No new non-conformities were identified during the assessment.



Ingen Technologies is strongly committed to the success of this company and continues driving forward in a direction that is within the best interest of its shareholders. The company has pending back-orders for export sales to China, Japan, Canada, Europe and Australia. Ingen has seen an increase in the value with its intellectual property, research & development, new medical product lines, inventory and other assets, while revenues show a steady incline. ISO Certification is expected to result in a large revenue jump of the company's respiratory product lines.

IGNT a leading manufacturer of respiratory medical devices, recently announced today that the company was granted approval of the Stage-I audit conducted by BSI America, Inc. Yesterdays close green. with great news watch for the run!! IMO

The most effective recommendations on how to get best stock is right here!

superalerts.info